Literature DB >> 21925517

Role of FAK in S1P-regulated endothelial permeability.

Patrick Belvitch1, Steven M Dudek.   

Abstract

The vascular endothelium serves as a semi-selective barrier between the circulating contents of the blood and the tissues through which they flow. Disruption of this barrier results in significant organ dysfunction during devastating inflammatory syndromes such as sepsis and acute lung injury (ALI). Sphingosine 1-phosphate (S1P) is an endogenous lipid regulator of endothelial permeability that produces potent barrier enhancement via actin and junctional protein rearrangement and resultant cytoskeletal changes. A key effector protein in this S1P response is focal adhesion kinase (FAK), a highly conserved cytoplasmic tyrosine kinase involved in the engagement of integrins and assembly of focal adhesions (FA) through the catalysis of multiple downstream signals. After stimulation by S1P, endothelial FAK undergoes specific tyrosine phosphorylation that results in activation of the kinase and dynamic interactions with other effector molecules to improve the endothelial barrier. FAK participates in peripheral actin cytoskeletal rearrangement as well as cell-matrix (FA) and cell-cell (adherens junction) junctional complex strengthening that combine to decrease vascular permeability. This review summarizes the current knowledge of the role of FAK in mediating enhanced endothelial barrier function by S1P.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925517      PMCID: PMC3684237          DOI: 10.1016/j.mvr.2011.08.012

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  90 in total

Review 1.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

Review 2.  The FERM domain: organizing the structure and function of FAK.

Authors:  Margaret C Frame; Hitesh Patel; Bryan Serrels; Daniel Lietha; Michael J Eck
Journal:  Nat Rev Mol Cell Biol       Date:  2010-11       Impact factor: 94.444

Review 3.  Sphingosine 1-phosphate receptor signaling.

Authors:  Hugh Rosen; Pedro J Gonzalez-Cabrera; M Germana Sanna; Steven Brown
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

4.  Endothelial permeability is controlled by spatially defined cytoskeletal mechanics: atomic force microscopy force mapping of pulmonary endothelial monolayer.

Authors:  Anna A Birukova; Fernando T Arce; Nurgul Moldobaeva; Steven M Dudek; Joe G N Garcia; Ratnesh Lal; Konstantin G Birukov
Journal:  Nanomedicine       Date:  2008-09-27       Impact factor: 5.307

5.  Nudel and FAK as antagonizing strength modulators of nascent adhesions through paxillin.

Authors:  Yongli Shan; Lihou Yu; Yan Li; Youdong Pan; Qiangge Zhang; Fubin Wang; Jianfeng Chen; Xueliang Zhu
Journal:  PLoS Biol       Date:  2009-05-26       Impact factor: 8.029

6.  Akt-mediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids.

Authors:  Patrick A Singleton; Santipongse Chatchavalvanich; Panfeng Fu; Junjie Xing; Anna A Birukova; Jennifer A Fortune; Alexander M Klibanov; Joe G N Garcia; Konstantin G Birukov
Journal:  Circ Res       Date:  2009-03-12       Impact factor: 17.367

7.  Enhanced interaction between focal adhesion and adherens junction proteins: involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement.

Authors:  Xiaoguang Sun; Yasushi Shikata; Lichun Wang; Kazuyoshi Ohmori; Naoko Watanabe; Jun Wada; Kenichi Shikata; Konstantin G Birukov; Hirofumi Makino; Jeffrey R Jacobson; Steven M Dudek; Joe G N Garcia
Journal:  Microvasc Res       Date:  2009-01-27       Impact factor: 3.514

Review 8.  Regulation of vascular permeability by sphingosine 1-phosphate.

Authors:  Lichun Wang; Steven M Dudek
Journal:  Microvasc Res       Date:  2008-09-30       Impact factor: 3.514

9.  The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells.

Authors:  Gian Carlo Alghisi; Lionel Ponsonnet; Curzio Rüegg
Journal:  PLoS One       Date:  2009-02-12       Impact factor: 3.240

10.  FAK alters invadopodia and focal adhesion composition and dynamics to regulate breast cancer invasion.

Authors:  Keefe T Chan; Christa L Cortesio; Anna Huttenlocher
Journal:  J Cell Biol       Date:  2009-04-13       Impact factor: 10.539

View more
  26 in total

1.  Interaction of integrin β4 with S1P receptors in S1P- and HGF-induced endothelial barrier enhancement.

Authors:  Xiuqin Ni; Yulia Epshtein; Weiguo Chen; Tingting Zhou; Lishi Xie; Joe G N Garcia; Jeffrey R Jacobson
Journal:  J Cell Biochem       Date:  2014-06       Impact factor: 4.429

2.  Role of N-WASP in Endothelial Monolayer Formation and Integrity.

Authors:  Olivia L Mooren; Joanna Kim; Jinmei Li; John A Cooper
Journal:  J Biol Chem       Date:  2015-06-12       Impact factor: 5.157

3.  Cortical Actin Dynamics in Endothelial Permeability.

Authors:  Patrick Belvitch; Yu Maw Htwe; Mary E Brown; Steven Dudek
Journal:  Curr Top Membr       Date:  2018-10-15       Impact factor: 3.049

4.  Sphingosine 1-phosphate (S1P) receptors 1 and 2 coordinately induce mesenchymal cell migration through S1P activation of complementary kinase pathways.

Authors:  Patrick Quint; Ming Ruan; Larry Pederson; Moustapha Kassem; Jennifer J Westendorf; Sundeep Khosla; Merry Jo Oursler
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

Review 5.  Similarities and differences in the regulation of leukocyte extravasation and vascular permeability.

Authors:  Dietmar Vestweber; Florian Wessel; Astrid Fee Nottebaum
Journal:  Semin Immunopathol       Date:  2014-03-18       Impact factor: 9.623

6.  S1PR1 Tyr143 phosphorylation downregulates endothelial cell surface S1PR1 expression and responsiveness.

Authors:  Alejandra Chavez; Tracy Thennes Schmidt; Pascal Yazbeck; Charu Rajput; Bhushan Desai; Sukriti Sukriti; Kristina Giantsos-Adams; Nebojsa Knezevic; Asrar B Malik; Dolly Mehta
Journal:  J Cell Sci       Date:  2015-01-14       Impact factor: 5.285

7.  Role played by paxillin and paxillin tyrosine phosphorylation in hepatocyte growth factor/sphingosine-1-phosphate-mediated reactive oxygen species generation, lamellipodia formation, and endothelial barrier function.

Authors:  Panfeng Fu; Peter V Usatyuk; Jeffrey Jacobson; Anne E Cress; Joe G N Garcia; Ravi Salgia; Viswanathan Natarajan
Journal:  Pulm Circ       Date:  2015-12       Impact factor: 3.017

8.  Cerebrovascular Angiogenic Reprogramming upon LRP1 Repression: Impact on Sphingosine-1-Phosphate-Mediated Signaling in Brain Endothelial Cell Chemotactism.

Authors:  Amélie Vézina; Cyndia Charfi; Alain Zgheib; Borhane Annabi
Journal:  Mol Neurobiol       Date:  2017-05-17       Impact factor: 5.590

Review 9.  Cellular and molecular regulation of vascular permeability.

Authors:  Lauren M Goddard; M Luisa Iruela-Arispe
Journal:  Thromb Haemost       Date:  2013-02-07       Impact factor: 5.249

10.  SH2 domain-containing protein tyrosine phosphatase 2 and focal adhesion kinase protein interactions regulate pulmonary endothelium barrier function.

Authors:  Havovi Chichger; Julie Braza; Huetran Duong; Elizabeth O Harrington
Journal:  Am J Respir Cell Mol Biol       Date:  2015-06       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.